Anxiety and medical disorders

Current Psychiatry Reports

Volumn 7, Issue 4, 2005, Pages 245-251

  Muller, Jacqueline E ^a   Koen, Liezl ^b   Stein, Dan J ^b  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUVOXAMINE; GABAPENTIN; IMIPRAMINE; LAMOTRIGINE; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; PREGABALIN; SERTRALINE; VALPROIC ACID;

ANXIETY DISORDER; BEHAVIOR THERAPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GENERALIZED ANXIETY DISORDER; HEAD INJURY; HUMAN; HYPERTHYROIDISM; JOINT HYPERMOBILITY; KLUVER BUCY SYNDROME; MITRAL VALVE PROLAPSE; NEUROBIOLOGY; OBSESSIVE COMPULSIVE DISORDER; PANIC; PARKINSON DISEASE; POSTTRAUMATIC STRESS DISORDER; RESPIRATORY TRACT DISEASE; REVIEW; RISK FACTOR; SEIZURE; SOCIAL PHOBIA;

EID: 24944565390     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-005-0077-5     Document Type: Review

References (96)

1. McLaughlin T, Geissler EC, Wan GJ: Comorbidities and associated treatment charges in patients with anxiety disorders. Pharmacotherapy 2003, 23:1251-1256.
2. Dew MA, Kormos RL, Roth LH, et al.: Early post-transplant medical compliance and mental health predict physical morbidity and mortality one to three years after heart transplantation. J Heart Lung Transplant 1999, 18:549-562.
3. Aydin IO, Ulusahin A: Depression, anxiety comorbidity, and disability in pulmonary tuberculosis and chronic obstructive pulmonary disease patients: applicability of GHQ-12. Gen Hosp Psychiatry 2001, 23:87-93.
4. Irvine EJ: Review article: patients' fears and unmet needs in inflammatory bowel disease. Aliment Pharmacol Ther 2004, 20(Suppl 4):54-59.
5. Shemesh E, Rudnik A, Kaluski E, et al.: A prospective study of posttraumatic stress symptoms and nonadherence in survivors of a myocardial infarction (MI). Gen Hosp Psychiatry 2001, 23:215-222.
6. Kessler RC, McGonagle KC, Zhao S, et al.: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994, 51:8-19.
7. Fleet RP, Dupuis G, Marchand A, et al.: Panic disorder in emergency department chest pain patients: prevalence, comorbidity, suicidal ideation, and physician recognition. Am J Med 1996, 101:371-380.
8. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
9. Gaitatzis A, Trimble MR, Sander JW: The Psychiatric comorbidity of epilepsy. Acta Neurol Scand 2004, 110:207-220.
10. Marsh L, Rao V: Psychiatric complications in patients with epilepsy: a review. Epilepsy Res 2002 Mar, 49(1):11-33.
11. Jackson MJ, Turkington D: Depression and anxiety in epilepsy. J Neurol Neurosurg Psychiatry 2005, 76(Suppl 1):i45-47.
12. Handal NM, Masand P, Weilburg JB: Panic disorder and complex partial seizures. A truly complex relationship. Psychosomatics 1995, 36:498-502.
13. Cendes FAFGP, Gambardella A, Lopez-Cendes I, et al.: Relationship between atrophy of the amygdala and ictal fear in temporal lobe epilepsy. Brain 1994, 117:739-746.
14. Vazquez B, Devinsky O: Epilepsy and anxiety. Epilepsy Behav 2003, 4 (Suppl 4):S20-25.
15. Klüver H, Bucy PC: Prelimanary analysis of functions of the temporal lobe in monkeys. Arch Neurol Psychiatry 1939, 42:979-1000.
16. Ketter TA, Post RM, Theodore WH: Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders. Neurology 1999, 53(Suppl 2):S53-67.
17. Boylan LS: Peri-ictal behavioral and cognitive changes. Epilepsy Behav 2002 Feb, 3:16-26.
18. Van Ameringen M, Mancini C, Pipe B, et al.: Antiepileptic drugs in the treatment of anxiety disorders: role in therapy. Drugs 2004, 64:2199-2220.
19. Klein DF: False suffocation alarms, spontaneous panics, and related conditions: an integrative hypothesis. Arch Gen Psychiatry 1993, 50:306-317.
20. Perna G, Gabriele A, Caldirola D, et al.: Hypersensitivity to inhalation of carbon dioxide and panic attacks. Psychiatry Res 1995, 57:267-273.
21. Porzelius J, Vest M, Nochomovitz M: Respiratory function, cognitions, and panic in chronic obstructive pulmonary patients. Behav Res Ther 1992, 30:75-77.
22. Katon WJ, Richardson L, Lozano P, et al.: The relationship of asthma and anxiety disorders. Psychosom Med 2004, 66:349-355.
23. Northcott CJ, Stein MB: Panic disorder in pregnancy. J Clin Psychiatry 1994, 55:539-542.
24. Pine DS, Weese-Mayer DE, Silvestri JM, et al.: Anxiety and congenital hypoventilation syndrome. Am J Psychiatry 1994, 151:864-870.
25. Perna G, Bertani A, Caldirola D, et al.: Modulation of hyper-reactivity to 35% CO2 after one week of treatment with paroxetine and reboxetine: a double-blind, randomized study. J Clin Psychopharmacol 2004, 24:277-282.
26. Bertani A, Perna G, Arancio C, et al.: Pharmacologic effect of imipramine, paroxetine, and sertraline on 35% carbon dioxide hypersensitivity in panic patients: a double-blind, random, placebo-controlled study. J Clin Psychopharmacol 1997, 17:97-101.
27. Pols HJ, Hauzer RC, Meijer JA, et al.: Fluvoxamine attenuates panic induced by 35% CO2 challenge. J Clin Psychiatry 1996, 57:539-542.
28. Fahrenfort JJ, Wilterdink AM, van der Veen EA: Long-term residual complaints and psychosocial sequel after remission of hyperthyroidism. Psychoneuroendocrinology 2000, 25:201-211.
29. Tukel R, Kora K, Hekim N, et al.: Thyrotropin stimulating hormone response to thyrotropin releasing hormone in patients with panic disorder. Psychoneuroendocrinology 1999, 24:155-160.
30. Kikuchi M, Komuro R, Oka H, et al.: Relationship between anxiety and thyroid function in patients with panic disorder. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:77-81.
31. Freed LA, Lewy D, Levine RA, et al.: Prevalence and clinical outcome of mitral valve prolapse. N Engl J Med 1999, 341:1-7.
32. Katerndahl DA: Panic and prolapse, meta-analysis. J Nerv Ment Dis 1993, 181:539-544.
33. Tamam L, Ozpoyraz N, San M, et al.: Association between idiopathic mitral valve prolapse and panic disorder. Croat Med J 2000 Dec, 41:410-416.
34. Toren P, Eldar S, Cendorf D, et al.: The prevalence of mitral valve prolapse in children with anxiety disorders. J Psychiatr Res 1999, 33:357-361.
35. Sullivan GM, Kent JM, Kleber M, et al.: Effects of hyperventilation on heart rate and QT variability in panic disorder pre- and post-treatment. Psychiatry Res 2004, 125:29-39.
36. Yeragani VK, Tancer M, Uhde T: Heart rate and QT interval variability: abnormal alpha-2 adrenergic function in patients with panic disorder. Psychiatry Res 2003, 121:185-196.
37. Kochiadakis GE, Parthenakis FI, Zuridakis EG, et al.: Is there increased sympathetic activity in patients with mitral valve prolapse? Pacing Clin Electrophysiol 1996, 19:1872-1876.
38. Bulbena A, Duro JC, Porta M, et al.: Anxiety disorders in joint hypermobility syndrome. Psychiatry Res 1993, 46:59-68.
39. Mishra MB, Ryan P, Atkinson P, et al.: Extra-articular features of benign joint hypermobility syndrome. Br J Rheumatol 1996, 35:861-866.
40. Gratacos M, Nadal M, Martin-Santos R, et al.: A polymorphic genomic duplication on human chromosome 15 is a susceptibility factor for panic and phobic disorders. Cell 2001, 106:367-379.
41. Tabiner M, Youings S, Dennis N, et al.: Failure to find DUP25 in patients with anxiety disorders, in control individuals, or in previously reported positive control cell lines. Am J Hum Genet 2003, 72:535-538.
42. Gulpek D, Bayraktar E, Akbay SP, et al.: Joint hypermobility syndrome and mitral valve prolapse in panic disorder. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:969-973.
43. Bulbena A, Agullo A, Pailhez G, et al.: Is joint hypermobility related to anxiety in a nonclinical population also? Psychosomatics 2004, 45:432-437.
44. Wittchen HU, Zhao S, Kessler RC, et al.: DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1994, 51:355-364.
45. Grigsby AB, Anderson RJ, Freedland KE, et al.: Prevalence of anxiety in adults with diabetes. A systematic review. J Psychosom Res 2002, 53:1053-1060.
46. Sonino N, Navarrini C, Ruini C, et al.: Persistent psychological distress in patients treated for endocrine disease. Psychother Psychosom 2004, 73:78-83.
47. Bunevicius R, Velickiene D, Prange AJ: Mood and anxiety disorders in women with treated hyperthyroidism and opthalmopathy caused by Graves' disease. Gen Hosp Psychiatry 2005, 27:133-139.
48. Stern RA, Robinson B, Thorner AR, et al.: A survey study of neuropsychiatric complaints in patients with Graves' disease. J Neuropsychiatry Clin Neurosci 1996, 8:181-185.
49. Lainscak M, Keber I: Patients view of heart failure: from the understanding to the quality of life. Eur J Cardiovasc Nur 2003, 2:275-281.
50. De Jong MJ, Chung ML, Roser LP, et al.: A five-country comparison of anxiety early after acute myocardial infarction. Eur J Cardiovasc Nurs 2004, 3:129-134.
51. Moser DK, Dracup K: Is anxiety early after myocardial infarction associated with subsequent ischeamic and arrhythmic events? Psychosom Med 1996, 58:395-401.
52. Sirois BC, Burg MM: Negative emotion and coronary heart disease. A review. Behav Modif 2003, 27:83-102.
53. Kawachi I, Sparrow D, Vokonas PS, et al.: Symptoms of anxiety and risk of coronary heart disease. The Normative Aging Study. Circulation 1994, 90:2225-2229.
54. Kawachi I, Sparrow D, Vokonas PS, et al.: Decreased heart rate variability in men with phobic anxiety (data from The Normative Aging Study). Am J Cardiol 1995, 75:882-885.
55. Richard IH, Schiffer RB, Kurlan R: Anxiety and Parkinson's disease. J Neuropsych Clin Neurosci 1996, 8:383-392.
56. Schneier FR, Liebowitz MR, Abi-Dargham A: Low dopamine D2 receptor binding potential in social phobia. Am J Psychiatry 2001, 157:457-459.
57. Stein DJ, Ipser JC, Balkom AJ: Pharmacotherapy for social phobia. Cochrane Database Syst Rev 2004, 4:CD001206.
58. Lauterbach EC, Freeman A, Vogel RL: Differential DSM-III psychiatric disorder prevalence profiles in dystonia and Parkinson's disease. J Neuropsychiatry Clin Neurosci 2004, 16:29-36.
59. Nuti A, Ceravolo R, Piccinni A, et al.: Psychiatric comorbidity in a population of Parkinson's disease patients. Eur J Neurol 2004 May, 11(5):315-320.
60. Vazquez A, Jimenez-Jimenez FJ, Garcia-Ruiz P, et al.: "Panic attacks" in Parkinson's disease. A long-term complication of levodopa therapy. Acta Neurol Scand 1993, 87:14-18.
61. Menza MA, Palermo B, DiPaola R, et al.: Depression and anxiety in Parkinson's disease: possible effect of genetic variation in the serotonin transporter. Geriatr Psychiatry Neurol 1999, 12:49-52.
62. Marsh L, Williams JR, Rocco M, et al.: Psychiatric comorbidities in patients with Parkinson's disease and psychosis. Neurology 2004, 63:293-300.
63. Menza M, Marin H, Kaufman K, et al.: Citalopram treatment of depression in Parkinson's disease: the impact on anxiety, disability, and cognition. Neuropsychiatry Clin Neurosci 2004, 16:315-319.
64. Murray CJL, Lopez AD: Global Burden of Disease: A Comprehensive Assessment of Mortality and Morbidity from Diseases, Injuries and Risk Factors in 1990 and projected to 2020. Vol I. Harvard, MA: World Health Organization; 1996.
65. Cheyette SR, Cummings JL: Encephalitis lethargica: lessons for contemporary neuropsychiatry. J Neuropsychiatry Clin Neurosci 1995, 7:125-134.
66. Stein DJ, Hollander E, Cohen L: Neuropsychiatry of obsessive-compulsive disorder. In Current Insights in Obsessive-compulsive Disorder. Edited by Hollander E, Zohar J, Marazitti D, Olivier B. Chichester: Wiley; 1994.
67. Hugo F, van Heerden B, Zungu-Dirwayi N, et al.: Functional brain imaging in obsessive-compulsive disorder secondary to neurological lesions. Depress Anxiety 1999, 10:129-136.
68. Zungu-Dirwayi N, Hugo F, van Heerden BB, et al.: Are musical obsessions a temporal lobe phenomenon? J Neuropsychiatry Clin Neurosci 1999, 11:398-400.
69. Swedo SE, Leonard HL, Garvey M, et al.: Pediatric autoimmune Neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 1998, 155:264-271.
70. Dale RC, Heyman I, Surtees RAH, et al.: Dyskinesias and associated psychiatric disorders following streptococcal infections. Arch Dis Child 2004, 89:604-610.
71. Mercadante MT, Busatto GF, Lombroso PJ, et al.: The psychiatric symptoms of rheumatic fever. Am J Psychiatry 2000, 157:2036-2038.
72. Swedo SE, Grant PJ: Annotation: PANDAS: a model for human autoimmune disease. J Child Psychol Psychiatry 2005, 46:227-234.
73. Giedd JN, Rapoport JL, Leonard HL, et al.: Case study: acute basal ganglia enlargement and obsessive-compulsive symptoms in an adolescent boy. J Am Acad Child Adolesc Psychiatry 1996, 35:913-915.
74. Singer HS: PANDAS and immunomodulatory therapy. Lancet 1999, 354:1137-1138.
75. Snider LA, Lougee L, Slattery M, et al.: Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders. Biol Psychiatry 2005, 57:788-792.
76. Garvey MA, Perlmutter SJ, Allen AJ, et al.: A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol Psychiatry 1999, 45:1564-1571.
77. Church AJ, Cardoso F, Dale RC, et al.: Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea. Neurology 2002, 59:227-231.
78. Singer HS, Loiselle CR, Lee O, et al.: Anti-basal ganglia antibodies in PANDAS. Mov Disord 2004, 19:406-415.
79. Singer HS, Loiselle CR, Lee O, et al.: Anti-basal ganglia antibody abnormalities in Sydenham chorea. J Neuroimmunol 2003, 136:154-161.
80. Tedstone JE, Tarrier N: Posttraumatic stress disorder following medical illness and treatment. Clin Psychol Rev 2003, 23:409-448.
81. McMillan TM: Post-traumatic stress disorder and severe head injury. Br J Psychiatry 1991, 159:431-433.
82. Lyons DM, Yang C, Sawyer-Glover AM, et al.: Early life stress and inherited variation in monkey hippocampal volumes. Arch Gen Psychiatry 2001, 58:1145-1151.
83. Seedat S, van der Westhuizen S, Matthey M, et al.: Temporal lobe structural lesion in a case of posttraumatic stress disorder. J Neuropsychiatry Clin Neurosci 2002, 14:240-241.
84. Asmundson GJG, Norton GR, Allerdings MD, et al.: Post-traumatic stress disorder and work-related injury. J Anxiety Disord 1998, 12:57-69.
85. Asmundson GJG, Wright KD, Stein MB: Pain and PTSD symptoms in female veterans. Eur J Pain 2004, 8:345-350.
86. Sharp TJ, Harvey AG: Chronic pain and posttraumatic stress disorder: mutual maintenance? Clin Psychol Rev 2001, 21:857-877.
87. Asmundson GJG, Coons MJ, Taylor S, et al.: PTSD and the experience of pain: research and clinical implications of shared vulnerability and mutual maintenance models. Can J Psychiatry 2002, 47:930-937.
88. Asmundson GJG, Wright KD, McCreary DR, et al.: Dimensionality of post-traumatic stress symptoms in military peace keepers. Cog Behav Ther 2003, 32:26-37.
89. Roy-Byrne P, Smith WR, Goldberg J, et al.: Post-traumatic stress disorder among patients with chronic pain and chronic fatigue. Psychol Med 2004 Feb, 34:363-368.
90. Raphael KG, Janal MN, Nayak S: Comorbidity of fibromyalgia and posttraumatic stress disorder symptoms in a community sample of women. Pain Med 2004, 5:33-41.
91. Kelly B, Raphael B, Judd F, et al.: Posttraumatic stress disorder in response to HIV infection. Gen Hosp Psychiatry 1998, 20:345-352.
92. Kimerling R, Calhoun KS, Forehand R, et al.: Traumatic stress in HIV-infected women. AIDS Educ Prev 1999, 11:321-330.
93. Smith MY, Egert J, Winkel G, et al.: The impact of PTSD on pain experience in persons with HIV/AIDS. Pain 2002, 98:9-17.
94. Tsao JCI, Dobalian A, Naliboff BD: Panic disorder and pain in a national sample of persons living with HIV. Pain 2004, 109:172-180.
95. Barrett JE, Barret JA, Oxman TE, et al.: The prevalence of psychiatric disorders in primary care practice. Arch Gen Psychiatry 1988, 45:1100-1106.
96. Wise TN: Part IX: Anxiety disorders in special populations. In Textbook of Anxiety Disorders. Edited by Stein DJ and Hollander E. Washington, DC: American Psychiatric Publishing; 2002.